BIOMAT Database Logo BIOMAT Database Logo

Inhibition of N-Glycosylation towards Novel Anti-Cancer Chemotherapeutics. 2018

Michio Kurosu
Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, 881 Madison Avenue, Memphis, TN 38163, USA.

UI MeSH Term Description Entries

Related Publications

Michio Kurosu
Anti-cancer activity of glucosamine through inhibition of N-linked glycosylation.
January 2014, Cancer cell international,
Michio Kurosu
Antibody-drug conjugates as novel anti-cancer chemotherapeutics.
June 2015, Bioscience reports,
Michio Kurosu
Inhibition of N-linked glycosylation.
May 2001, Current protocols in protein science,
Michio Kurosu
Inhibition of N-linked glycosylation.
May 2001, Current protocols in immunology,
Michio Kurosu
Inhibition of N-linked glycosylation.
May 2001, Current protocols in molecular biology,
Michio Kurosu
Hyaluronan: towards novel anti-cancer therapeutics.
January 2013, Pharmacological reports : PR,
Michio Kurosu
Dimeric approaches to anti-cancer chemotherapeutics.
October 2008, Anti-cancer agents in medicinal chemistry,
Michio Kurosu
New Trends in Anti-Cancer Therapy: Combining Conventional Chemotherapeutics with Novel Immunomodulators.
January 2018, Current medicinal chemistry,
Michio Kurosu
Pancreatic cancer: medical management (novel chemotherapeutics).
March 2012, Gastroenterology clinics of North America,
Michio Kurosu
Amphiphilic glycoconjugates as potential anti-cancer chemotherapeutics.
January 2018, European journal of medicinal chemistry,
Copied contents to your clipboard!